• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: EDWARDS LIFESCIENCES EDWARDS INTUITY ELITE VALVE SYSTEM; TISSUE, HEART-VALVE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

EDWARDS LIFESCIENCES EDWARDS INTUITY ELITE VALVE SYSTEM; TISSUE, HEART-VALVE Back to Search Results
Model Number 8300AB23
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Syncope (1610); Arrhythmia (1721); Infarction, Cerebral (1771); Death (1802); Fall (1848); Bone Fracture(s) (1870); Hematoma (1884); Respiratory Failure (2484); Complete Heart Block (2627)
Event Date 09/04/2019
Event Type  Injury  
Manufacturer Narrative
Udi number: (b)(4).Peri-procedural arrhythmias, heart block, and other conduction disturbances are common in patients with underlying cardiovascular disease and/or conduction abnormalities.They can be exacerbated with standard perioperative medications, anesthesia, and/or instrumentation of the heart.Temporary pacemakers are inserted in all patients undergoing aortic valve replacement (avr).It is not uncommon for patients to have short term/reversible periods of heart block or arrhythmias following the procedure while their heart recovers from cardiopulmonary bypass.In many cases, the temporary pm is left in the patient for a short time following the procedure and then subsequently removed prior to discharge.Following surgical aortic valve replacement (avr), new-onset bundle branch block has been reported in 16% to 32% of patients and the need for permanent pacemakers in 3% to 8% of patients.The reason for post-operative av block after surgical avr is related to injury to the cardiac conduction system during surgical excision of the adjacent diseased valve and annular tissue.The close anatomical relationship between the aortic valvular complex and the branching atrioventricular bundle explains the possible development of conduction abnormalities following prosthetic aortic valve procedures.The root cause of this event cannot be determined with the available information.However, there is no information suggesting there was any device malfunction and/or deficiency.The device history record (dhr) review was completed and this device passed all manufacturing and sterilization inspections prior to release for distribution.Edwards will continue to review and monitor all reported events.Trends are monitored on a monthly basis and if action is required, appropriate investigation will be performed.The subject device is not available for evaluation, as it remains implanted in the patient.
 
Event Description
It was reported via the implant patient registry that a patient with a 23mm 8300ab pericardial aortic valve developed complete heart block on pod #2.Per received medical records, the patient tolerated the initial avr and cabg procedure well and without complications.The patient was transferred to the icu in stable condition.On pod #2, he developed chb that converted to nsr.A beta block was initiated, but was discontinued due to hypotension.The patient remained in nsr.On pod #8, the patient had a syncope episode and fell.Cpr was initiated due to heart block, placement of temporary pacing wires were unsuccessful.He was emergently taken to the or and transvenous pacer wires were inserted and thresholds were acceptable.The patient was unable to wean from cpb and tee revealed severely depress rv.Va-ecmo was placement.On pod #9, head ct showed no acute intracranial hemorrhage or mass effect, but nasal fracture, frontal hematoma, and rib fractures.He return to the or and va-ecmo was removed, echo showed moderately depressed rv and lvef 45%, and aortic valve with no pvl.Ep cardiology was consulted for ppm.Due to concern for neurological deficits, repeat head ct was performed on pod #11 which revealed large watershed distribution infarctions in the cerebral hemispheres bilaterally.The patient continued to be supported for chb, acute respiratory failure, aki, and pna.On pod #14, the patient was made dnr with comfort care and subsequently expired on pod #15.
 
Manufacturer Narrative
Updated: h6.
 
Manufacturer Narrative
Reference capa-20-00141.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
EDWARDS INTUITY ELITE VALVE SYSTEM
Type of Device
TISSUE, HEART-VALVE
Manufacturer (Section D)
EDWARDS LIFESCIENCES
1 edwards way
irvine CA 92614
MDR Report Key10352239
MDR Text Key202706442
Report Number2015691-2020-12881
Device Sequence Number1
Product Code LWR
Combination Product (y/n)N
PMA/PMN Number
P150036
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional,other,use
Type of Report Initial,Followup,Followup
Report Date 09/02/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received07/31/2020
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date03/13/2021
Device Model Number8300AB23
Was Device Available for Evaluation? No
Date Manufacturer Received07/23/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Other; Required Intervention;
Patient Age78 YR
-
-